[What you need to know about the Moderna and Pfizer coronavirus vaccines] Researchers in the United States set an audacious goal in January last year to develop a coronavirus vaccine within 12 to ...

Just over half of U.S. adults (53%) say they’ve gotten neither the flu shot nor the updated COVID-19 vaccine since last ...

Pfizer's Covid-19 vaccine is considered by healthcare authorities to be safe and effective, with data gathered from billions ...

The latest generation of COVID-19 vaccines demonstrates remarkable precision in addressing current viral threats. The mRNA vaccines from Pfizer and Moderna specifically target the KP.2 variant ...

Next: Get access to a new market-moving chart every ... company’s COVID-19 vaccines due to reduced market demand. In addition, write-downs by BioNTech’s collaboration partner Pfizer Inc ...

His time at Pfizer has coincided with the spectacular success of its BioNTech-partnered mRNA vaccine for COVID-19 – Comirnaty – and as GSK itself struggled to make headway with its own ...

A healthcare worker fills a syringe with the Pfizer COVID-19 vaccine at Jackson Memorial Hospital, Oct. 5, 2021, in Miami. Lynne Sladky/AP The CDC, however, has previously stated vaccination ...

Vaccine hesitancy and higher rates of school vaccine exemptions increases the risk of outbreaks of preventable diseases, ...

Given the uncertainty around its top-line growth, short-term investors should exercise caution when investing in MRNA stock.

the breakthrough technology behind COVID-19 vaccines from Moderna and Pfizer-BioNTech. Despite COVID vaccines saving an estimated 3 million American lives in the first few years mRNA shots were on ...